A Win For Foghorn Therapeutics Inc.
Thu, Feb 08, 2024 at 07:14 PM
Foghorn Therapeutics Inc. (FHTX:NASDAQ) rocketted at $4.85, a gain of 55.4%. On Thu, Feb 08, 2024, FHTX:NASDAQ hit a New 2-Week High of $4.85. The stock got featured on our News Catalysts scanner on Thu, Feb 08, 2024 at 08:06 AM in the 'INVESTOR UPDATE' category. From Thu, Jan 25, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days
About Foghorn Therapeutics Inc. (FHTX:NASDAQ)
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system.
Top 10 Gainers:
- Syra Health Corp. (SYRA:NASDAQ), 321.74%
- Hitek Global Inc. (HKIT:NASDAQ), 218.42%
- NanoString Technologies, Inc. (NSTG:NASDAQ), 118.42%
- Renalytix AI plc (RNLX:NASDAQ), 96.87%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 83.4%
- MicroAlgo Inc. (MLGO:NASDAQ), 82.46%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 59.44%
- MoneyHero Limited (MNY:NASDAQ), 59.09%
- Foghorn Therapeutics Inc. (FHTX:NASDAQ), 55.45%
- Arm Holdings plc (ARM:NASDAQ), 47.89%